Oncolytics Biotech (oncy) Misses Q3 EPS by 25c

Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.

For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• After-Hours Stock Movers: FDX, CBRS, NKE